Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-20

Clinical Trial Update: Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure [Phase 4]

View source ↗

Summary

Phase 4 study assessing the efficacy of Everolimus on renal function in heart transplant recipients with established chronic renal failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Everolimus (everolimus)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cardiac Transplantation, Chronic Renal Insufficiency | Phase 4 | Status: COMPLETED